Results 11 to 20 of about 3,321,094 (294)
Tumor suppressor genes in the tumor microenvironment [PDF]
Disease Models & MechanismsABSTRACT Tumor suppressor genes (TSGs) are thought to suppress tumor development primarily via cancer cell-autonomous mechanisms. However, the tumor microenvironment (TME) also significantly influences tumorigenesis. In this context, a role for TSGs in the various cell types of the TME in regulating tumor growth is emerging.
Bahareh Tabanifar +2 more
doaj +4 more sources
Oncogenes and tumor suppressor genes
Ca-A Cancer Journal for Clinicians, 1994 In the past 15 years, many of the mechanisms underlying the molecular origins of cancer have been uncovered, and a clear picture of the role of oncogenes and tumor suppressor genes in carcinogenesis has developed. This article reviews the mechanisms by which oncogenes and tumor suppressor genes participate in the creation of tumors.
Robert Weinberg
exaly +6 more sources
p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes [PDF]
Cell Death DiscoveryThe transcription factor regulatory factor X 7 (RFX7) has been identified as a tumor suppressor that is recurrently mutated in lymphoid cancers and appears to be dysregulated in many other cancers. RFX7 is activated by the well-known tumor suppressor p53
Katjana Schwab +6 more
doaj +2 more sources
Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma [PDF]
Liver Research, 2021 Hepatocellular carcinoma (HCC) is a very deadly disease. HCC initiation and progression involve multiple genetic events, including the activation of proto-oncogenes and disruption of the function of specific tumor suppressor genes.
Fang Wang, Peter Breslin S J, Wei Qiu
doaj +2 more sources
TUMOR SUPPRESSOR GENE MUTATIONS IN MICE
Annual Review of Genetics, 1996 ▪ Abstract Over the past several years, a number of human tumor suppressor genes have been cloned and characterized. Germline mutations in tumor suppressor genes strongly predispose to cancer, and they are also mutated somatically in sporadic forms of the disease.
Tyler Jacks
exaly +4 more sources
Genetics (Tumor Suppressor Genes) and Breast Cancer Risk Bibliography [PDF]
, 2003 Bibliography on tumor suppressor genes and breast cancer riskBibliography on tumor suppressor genes and breast cancer risk. Includes review articles, commentaries, studies on p53 and BRCA genes, commentaries on genetic testing, emerging tumor suppressor ...
Snedeker, Suzanne M.
core +5 more sources
Frontiers in Immunology, 2021 Non-small-cell lung cancers (NSCLCs) are largely classified into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), which have different therapeutic options according to its molecular profiles and immune checkpoint expression, especially
Ahreum Kim +6 more
doaj +1 more source
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study. [PDF]
Ca-A Cancer Journal for CliniciansYan Yu, Diansheng Zhong, Lin Wu
exaly +2 more sources
Synthetic lethal approaches to target cancers with loss of PTEN function
Genes and Diseases, 2023 Phosphatase and tensin homolog (PTEN) is a tumor suppressor gene and has a role in inhibiting the oncogenic AKT signaling pathway by dephosphorylating phosphatidylinositol 3,4,5-triphosphate (PIP3) into phosphatidylinositol 4,5-bisphosphate (PIP2).
Ayse Ertay, Rob M. Ewing, Yihua Wang
doaj +1 more source
Biomolecules, 2022 Epstein-Barr virus (EBV) is ubiquitous and carried by approximately 90% of the world’s adult population. Several mechanisms and pathways have been proposed as to how EBV facilitates the pathogenesis and progression of malignancies, such as Hodgkin’s ...
Adelaide Ohui Fierti +4 more
doaj +1 more source